Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Total Liabilities (2016 - 2022)

Historic Total Liabilities for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $158.2 million.

  • Avadel Pharmaceuticals' Total Liabilities fell 419.91% to $158.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $158.2 million, marking a year-over-year decrease of 419.91%. This contributed to the annual value of $169.0 million for FY2021, which is 1315.52% up from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Total Liabilities stood at $158.2 million for Q3 2022, which was down 419.91% from $161.3 million recorded in Q2 2022.
  • Avadel Pharmaceuticals' Total Liabilities' 5-year high stood at $264.8 million during Q1 2018, with a 5-year trough of $149.4 million in Q4 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' median Total Liabilities value was $169.0 million (recorded in 2021), while the average stood at $178.0 million.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Total Liabilities skyrocketed by 3266.48% in 2018, and later tumbled by 3081.6% in 2019.
  • Over the past 5 years, Avadel Pharmaceuticals' Total Liabilities (Quarter) stood at $187.5 million in 2018, then fell by 3.67% to $180.6 million in 2019, then dropped by 17.31% to $149.4 million in 2020, then rose by 13.16% to $169.0 million in 2021, then dropped by 6.4% to $158.2 million in 2022.
  • Its Total Liabilities stands at $158.2 million for Q3 2022, versus $161.3 million for Q2 2022 and $165.9 million for Q1 2022.